BioMed Research International
Volume 2015 (2015), Article ID 409245, 13 pages
http://dx.doi.org/10.1155/2015/409245

Review Article

Ca²⁺ Signaling in Cytoskeletal Reorganization, Cell Migration, and Cancer Metastasis

Feng-Chiao Tsai,1,2 Guan-Hung Kuo,¹ Shu-Wei Chang,¹ and Pei-Ju Tsai¹

¹Department of Pharmacology, National Taiwan University College of Medicine, No. 1, Section 1, Ren-Ai Road, Taipei 100, Taiwan
²Department of Internal Medicine, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei 100, Taiwan

Received 17 December 2014; Accepted 12 March 2015

Academic Editor: Hiroshi Hasegawa

Copyright © 2015 Feng-Chiao Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Proper control of Ca²⁺ signaling is mandatory for effective cell migration, which is critical for embryonic development, wound healing, and cancer metastasis. However, how Ca²⁺ coordinates structural components and signaling molecules for proper cell motility had remained elusive. With the advance of fluorescent live-cell Ca²⁺ imaging in recent years, we gradually understand how Ca²⁺ is regulated spatially and temporally in migrating cells, driving polarization, protrusion, retraction, and adhesion at the right place and right time. Here we give an overview about how cells create local Ca²⁺ pulses near the leading edge, maintain cytosolic Ca²⁺ gradient from back to front, and restore Ca²⁺ depletion for persistent cell motility. Differential roles of Ca²⁺ in regulating various effectors and the interaction of roles of Ca²⁺ signaling with other pathways during migration are also discussed. Such information might suggest a new direction to control cancer metastasis by manipulating Ca²⁺ and its associating signaling molecules in a judicious manner.

1. Introduction

Calcium is one of the most important chemical elements for human beings. At the organismic level, calcium together with other materials composes bone to support our bodies [1]. At the tissue level, the compartmentalization of calcium ions (Ca²⁺) regulates membrane potentials for proper neuronal [2] and cardiac [3] activities. At the cellular level, increases in Ca²⁺ trigger a wide variety of physiological processes, including proliferation, death, and migration [4]. Aberrant Ca²⁺ signaling is therefore not surprising to induce a broad spectrum of diseases in metabolism [1], neuron degeneration [5], immunity [6], and malignancy [7]. However, though tremendous efforts have been exerted, we still do not fully understand how this tiny divalent cation controls our lives.

Such a puzzling situation also exists when we consider Ca²⁺ signaling in cell migration. As an essential cellular process, cell migration is critical for proper physiological activities, such as embryonic development [8], angiogenesis [9], and immune response [10], and pathological conditions, including immunodeficiency [11], wound healing [12], and cancer metastasis [13]. In either situation, coordination between multiple structural (such as F-actin and focal adhesion) and regulatory (such as Rac1 and Cdc42) components is required for cell migration processes (or modules), including polarization, protrusion, retraction, and adhesion [8]. Since Ca²⁺ signaling is meticulously controlled temporally and spatially in both local and global manners, it serves as a perfect candidate to regulate cell migration modules. However, although the significant contribution of Ca²⁺ to cell motility has been well recognized [14], it had remained elusive how Ca²⁺ was linked to the machinery of cell migration. The advances of live-cell fluorescent imaging for Ca²⁺ and cell migration in recent years gradually unravel the mystery, but there is still a long way to go.

In the present paper, we will give a brief overview about how Ca²⁺ signaling is polarized and regulated in migrating cells, its local actions on the cytoskeleton, and its global effect on cell migration and cancer metastasis. The strategies employing Ca²⁺ signaling to control cell migration and cancer metastasis will also be discussed.

2. History: The Journey to Visualize Ca²⁺ in Live Moving Cells

The attempt to unravel the roles of Ca²⁺ in cell migration can be traced back to the late 20th century, when fluorescent probes were invented [15] to monitor intracellular Ca²⁺ in live cells [16]. Using migrating eosinophils loaded with Ca²⁺ sensor Fura-2, Brundage et al. revealed that the cytosolic Ca²⁺ level was lower in the front than the back of the migrating cells. Furthermore, the decrease of regional Ca²⁺ levels could be used as a marker to predict the cell front before the eosinophil moved [17]. Such a Ca²⁺ gradient in migrating cells was also confirmed by other research groups [18], though its physiological significance had not been totally understood.

In the meantime, the importance of local Ca²⁺ signals in migrating cells was also noticed. The use of small molecule inhibitors and Ca²⁺ channel activators suggested that local Ca²⁺ in the back of migrating cells regulated retraction and adhesion [19]. Similar approaches were also recruited to indirectly demonstrate the Ca²⁺ influx in the cell front as the polarity determinant of migrating macrophages [14]. Unfortunately, direct visualization of local Ca²⁺ signals was not available in those reports due to the limited capabilities of imaging and Ca²⁺ indicators in early days.

The above problems were gradually resolved in recent years with the advance of technology. First, the utilization of high-sensitive camera for live-cell imaging [20] reduced the power requirement for the light source, which eliminated phototoxicity and improved cell health. A camera with high sensitivity also improved the detection of weak fluorescent signals, which is essential to identify Ca²⁺ pulses of nanomolar scales [21]. In addition to the camera, the emergence of genetic-encoded Ca²⁺ indicators (GECIs) [22, 23], which are fluorescent proteins engineered to show differential signals based on their Ca²⁺-binding statuses, revolutionized Ca²⁺ imaging. Compared to small molecule Ca²⁺ indicators, GECIs’ high molecular weights make them less diffusible, enabling the capture of transient local signals. Furthermore, signal peptides could be attached to GECIs so the recombinant proteins could be located to different compartments, facilitating Ca²⁺ measurements in different organelles. Such tools dramatically improved our knowledge regarding the dynamic and compartmentalized characteristics of Ca²⁺ signaling.

With the above techniques, “Ca²⁺ flickers” were observed in the front of migrating cells [18], and their roles in cell motility were directly investigated [24]. Moreover, with the integration of multidisciplinary approaches including fluorescent microscopy, systems biology, and bioinformatics, the spatial role of Ca²⁺, including the Ca²⁺ gradient in migrating cells, was also gradually clarified [25]. Our present understanding about Ca²⁺ signaling in migrating cells is briefly summarized as follows.

3. Ca²⁺ Transporters Regulating Cell Migration

3.1. Generators of Local Ca²⁺ Pulses: Inositol Triphosphate (IP₃) Receptors and Transient Receptor Potential (TRP) Channels (Figure 1)

Figure 1: Local Ca²⁺ pulses control retraction and adhesion around the leading edge of migrating cells. (a) Polarized receptor tyrosine kinase (RTK) signaling generates inositol triphosphate (IP₃) in front of migrating cells, which sensitizes IP₃ receptors (IP₃R) to release Ca²⁺ periodically from the endoplasmic reticulum (ER). IP₃R are also triggered by Ca²⁺-induced Ca²⁺ release (CICR), which originates from transient receptor potential (TRP) channels, mainly TRPM7. (b) Local Ca²⁺ pulses activate myosin light chain kinase (MLCK, shown as ML in the illustration), which phosphorylates myosin II for proper actin treadmilling and recycling. (c) Local Ca²⁺ pulse-triggered myosin contraction also enhances the formation of focal adhesion (FA) complexes, probably via force-induced positive feedback. Please notice the temporal correlation (as shown by dotted lines and arrowheads) and oscillatory dynamics between local Ca²⁺ pulses, front retraction, and FA. MY: myosin II; ML: myosin light chain kinase; I: integrin; ECM: extracellular matrix.

For a polarized cell to move efficiently, its front has to coordinate activities of protrusion, retraction, and adhesion [8]. The forward movement starts with protrusion, which requires actin polymerization in lamellipodia and filopodia, the foremost structure of a migrating cell [8, 13, 26]. At the end of protrusion, the cell front slightly retracts and adheres [27] to the extracellular matrix. Those actions occur in lamella, the structure located behind lamellipodia. Lamella recruits myosin to contract and dissemble F-actin in a treadmill-like manner and to form nascent focal adhesion complexes in a dynamic manner [28]. After a successful adhesion, another cycle of protrusion begins with actin polymerization from the newly established cell-matrix adhesion complexes. Such protrusion-slight retraction-adhesion cycles are repeated so the cell front would move in a caterpillar-like manner.

For the above actions to proceed and persist, the structural components, actin and myosin, are regulated in a cyclic manner. For actin regulation, activities of small GTPases, Rac, RhoA, and Cdc42 [29], and protein kinase A [30] are oscillatory in the cell front for efficient protrusion. For myosin regulation, small local Ca²⁺ signals are also pulsatile in the junction of lamellipodia and lamella [24]. Those pulse signals regulate the activities of myosin light chain kinase (MLCK) and myosin II, which are responsible for efficient retraction and adhesion [31, 32]. Importantly, due to the extremely high affinity between Ca²⁺-calmodulin complexes and MLCK [33], small local Ca²⁺ pulses in nanomolar scales are sufficient to trigger significant myosin activities.

The critical roles of local Ca²⁺ pulses in migrating cells raise the question where those Ca²⁺ signals come from. In a classical signaling model, most intracellular Ca²⁺ signals originate from endoplasmic reticulum (ER) through inositol triphosphate (IP₃) receptors [34, 35], which are activated by IP₃ generated via receptor-tyrosine kinase- (RTK-) phospholipase C (PLC) signaling cascades. It is therefore reasonable to assume that local Ca²⁺ pulses are also generated from internal Ca²⁺ storage, that is, the ER. In an in vitro experiment, when Ca²⁺ chelator EGTA was added to the extracellular space, local Ca²⁺ pulses were not immediately eliminated from the migrating cells [24], supporting the above hypothesis. Moreover, pan-RTK inhibitors that quenched the activities of RTK-PLC-IP₃ signaling cascades reduced local Ca²⁺ pulses efficiently in moving cells [25]. The observation of enriched RTK and PLC activities at the leading edge of migrating cells was also compatible with the accumulation of local Ca²⁺ pulses in the cell front [25]. Therefore, polarized RTK-PLC-IP₃ signaling enhances the ER in the cell front to release local Ca²⁺ pulses, which are responsible for cyclic moving activities in the cell front.

In addition to RTK, the readers may wonder about the potential roles of G protein-coupled receptors (GPCRs) on local Ca²⁺ pulses during cell migration. As the major pathway to activate PLC, GPCRs coupled to the subunit [36] trigger the cleavage of phosphatidylinositol (4,5)-bisphosphate (PIP₂) by PLC to generate diacylglycerol (DAG) and IP₃, which subsequently releases Ca²⁺ from the ER as Ca²⁺ pulses and spikes [37]. Indeed, Ca²⁺ oscillations induced by GPCR pathways have been observed in various cell types [38, 39]. However, the GPCRs coupled to and PLC include serotonergic, adrenergic, muscarinic, glutamatergic, and histamine receptors [37], most of which do not directly affect cell migration. In contrast, growth factors contributing to cell migration, such as fibroblast growth factor (FGF) [40], epidermal growth factor (EGF) [41], and vascular endothelial growth factor (VEGF) [42], activate RTK signaling pathways. Therefore, it is more likely for the RTK rather than GPCR pathway to be responsible for local Ca²⁺ pulses in migrating cells. Nonetheless, more studies are required to clarify this important question.

The readers may also be curious how nonpulsatile RTK-PLC signaling generates oscillatory local Ca²⁺ pulses. In fact, IP₃-induced Ca²⁺ oscillation has been reported repeatedly in various physiological circumstances [34, 38, 43, 44]. One possibility is that RTK signaling sensitizes IP₃ receptors in the front ER but does not directly open those Ca²⁺ channels. Alternatively, the cyclic Ca²⁺ channel opening could be triggered by Ca²⁺-induced Ca²⁺ release (CICR), which is the activation of IP₃ receptors by small changes of local Ca²⁺ levels [45, 46]. In the protruding cell front, the change of membrane tension may open stretch-activated transient receptor potential (TRP) channels [47], offering the required CICR. Indeed, TRP channels have been extensively reported as major contributors for cell migration and cancer metastasis [48]. Specifically, TRPM7 has been revealed to enhance cancer cell metastasis [49, 50], by mediating Ca²⁺ influx [51], altering Ca²⁺ flickers [18, 52], and regulating cell-matrix adhesion [53]. Therefore, oscillatory small Ca²⁺ pulses in the migrating cell front are probably the integrated results of polarized RTK signaling interacting with pulsatile membrane stretch and TRP channel opening, to release Ca²⁺ periodically from the front ER.

3.2. Maintainers of Basal Ca²⁺ Levels and Gradient: Sarcoplasmic/Endoplasmic Reticulum Ca²⁺-ATPase (SERCA) and Plasma Membrane Ca²⁺-ATPase (PMCA) (Figure 2)

Figure 2: Cytosolic Ca²⁺ levels are low in the front and high in the back of the migrating cell. The Ca²⁺ gradient is created by the differential distribution of plasma membrane Ca²⁺-ATPase (PMCA, shown as P in the illustration), resulting in higher pump activity to move cytosolic Ca²⁺ out of the cell in the front than the back. Low Ca²⁺ in the front “starves” myosin light chain kinase (MLCK), which is essential for its reactivity to local Ca²⁺ pulses. High Ca²⁺ in the back facilitates the turnover of stable focal adhesion complexes. (See Figure 4 and the text for more details.)

The fact that tiny cyclic Ca²⁺ signals induce significant changes of cell motility implies that the basal cytosolic Ca²⁺ level, especially that at the front of migrating cells, has to be extremely low, so the cell migration machinery, specifically myosin and focal adhesion complexes, can promptly respond to small Ca²⁺ changes. To achieve the above goal, the migrating cells meticulously utilize two types of Ca²⁺-ATPase pumps, sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase (SERCA) and plasma membrane Ca²⁺-ATPase (PMCA).

3.2.1. SERCA Pumps Cytosolic Ca²⁺ into the ER

SERCA is transmembranously located at the ER, continuously pumping cytosolic Ca²⁺ into the ER lumen with fast speed and high affinity [4]. Although their activities are slightly regulated by phospholamban and protein kinase A (PKA) [54], these pumps maintain the internal Ca²⁺ storage with high fidelity. Once SERCA is inactivated, the ER luminal Ca²⁺ leaks out to the cytoplasm in no time [55]. The resulting high cytosolic Ca²⁺ will saturate MLCK and induce persistent contraction of myosin [25], rendering front protrusion not possible. Furthermore, SERCA dysfunction dramatically reduces the ER luminal Ca²⁺, disabling further Ca²⁺ signaling through IP₃ receptors. Hence, SERCA is essential for physiological and pathological cell migration. It is therefore not surprising to see aberrant SERCA expressions in cancer progression, invasion, and metastasis [56, 57].

3.2.2. SERCA Is Not Responsible for the Cytosolic Ca²⁺ Gradient in Migrating Cells

Since SERCA continuously and efficiently removes Ca²⁺ out of the cytoplasm into the ER, it is convenient to hypothesize that cytosolic Ca²⁺ gradient in migrating cells results from differential SERCA activities. If the SERCA activity was higher in the front than in the back, more Ca²⁺ in the front cytosol would be pumped into the front ER, resulting in the low-in-front, high-in-back Ca²⁺ gradient in the cytoplasm and a reverse (high-in-front, low-in-back) gradient in the ER. However, blocking SERCA activities with small molecule inhibitors caused a paradoxical increase of Ca²⁺ gradient, in addition to the global increase of cytosolic Ca²⁺ [25]. Monitoring intra-ER Ca²⁺ with the T1ER FRET probe [58] also revealed a low-in-front, high-in-back Ca²⁺ gradient when the cell moved [25]. Therefore, though a pivotal molecule keeps the cytosol Ca²⁺ free at the basal status, SERCA does not contribute to the Ca²⁺ gradient in migrating cells.

3.2.3. Differential PMCA Activities Keep [Ca²⁺] in the Front Lower Than the Back during Cell Migration

Based on the above data, Ca²⁺ pumps at the plasma membrane might be better candidates for the Ca²⁺ gradient during cell migration. Similar to SERCA, PMCA also continuously removes cytosolic Ca²⁺, by pumping it to the extracellular space [4, 59]. Unlike SERCA, recent evidence revealed that PMCA inhibitors and siRNA reduced Ca²⁺ gradient and cell motility during cell migration [25]. Direct measurement of Ca²⁺ efflux through plasma membrane also demonstrated an enhancement of PMCA activity by 30–50% in the front of migrating cells [25]. Hence, differential PMCA activities might account for the Ca²⁺ gradient during cell migration.

It is still not totally understood how cells adjust local PMCA activities to make them high in the front and low in the back. Several modulators have been demonstrated to regulate PMCA, including calmodulin [60], PKA [61], and calpain [62]. Whether those proteins could be spatially regulated inside the cells remains elusive. In addition, PMCA was enriched in the front plasmalemma of moving cells [25], suggesting that its differential distribution might account for the well-recognized front-low, back-high Ca²⁺ gradient during cell migration. Still, how PMCA is accumulated in the cell front requires further investigation.

3.3. Maintainers of Ca²⁺ Homeostasis during Migration: Store-Operated Ca²⁺ (SOC) Influx (Figure 3)

Figure 3: Internal Ca²⁺ storage is maintained through the differential activities of store-operated Ca²⁺ (SOC) influx during cell migration. Repetitive Ca²⁺ release from inositol triphosphate (IP₃) receptors causes the depletion of Ca²⁺ in the endoplasmic reticulum (ER) near the leading edge. Such Ca²⁺ depletion activates STIM1 (shown as ST in the illustration), which is translocated to the ER-plasma membrane junction to open Ca²⁺ channels ORAI1 (shown as O in the illustration). The inward Ca²⁺ current through ORAI1 will further travel into the ER via sarcoplasmic/endoplasmic reticular Ca²⁺-ATPase (SERCA, shown as SE in the illustration). In migrating cells, STIM1 proteins are enriched in the front ER to maintain Ca²⁺ homeostasis, which is essential for proper polarity and motility.

Figure 4: Ca²⁺ is temporally and spatially regulated to control the cell migration machinery via a wide variety of effectors. (Right) In the front, Ca²⁺ activates myosin and protein kinase C (PKC) for the maintenance of polarity and establishment of nascent cell-matrix adhesion. (Left) In the back, Ca²⁺ mediates calpain and miscellaneous focal-adhesion (FA) regulators, so proper disassembly of stable FA complexes can proceed. DAG: diacylglycerol; PMCA: plasma membrane Ca²⁺-ATPase.

SOC influx is an essential process to maintain internal Ca²⁺ storage [63] for IP₃ receptor-based Ca²⁺ signaling, during which the luminal ER Ca²⁺ is evacuated. After IP₃-induced Ca²⁺ release, although Ca²⁺ can be recycled back to the ER through SERCA, a significant amount of cytosolic Ca²⁺ will be pumped out of the cell through PMCA, resulting in the depletion of internal Ca²⁺ storage. To rescue this, low luminal Ca²⁺ activates STIM1 [55, 64], which is a membranous protein located at the ER and transported to the cell periphery by microtubules [65, 66]. Active STIM1 will be translocated to the ER-plasma membrane junction [67], opening the Ca²⁺ influx channel ORAI1 [68, 69]. Ca²⁺ homeostasis could therefore be maintained during active signaling processes including cell migration.

Since the identification of STIM1 and ORAI1 as the major players of SOC influx, numerous reports have emerged confirming their significant roles in cell migration and cancer metastasis (Tables 1 and 2). Although it is reasonable for those Ca²⁺-regulatory molecules to affect cell migration, the molecular mechanism is still not totally clear. Recent experimental evidence implied that STIM1 helped the turnover of cell-matrix adhesion complexes [7, 25], so SOC influx may assist cell migration by maintaining local Ca²⁺ pulses in the front of migrating cells. In a moving cell, local Ca²⁺ pulses near its leading edge result in the depletion of Ca²⁺ in its front ER. Such depletion subsequently activates STIM1 at the cell front. Compatible with the above assumption, more STIM1 was translocated to the ER-plasma membrane junction in the cell front compared to its back during cell migration [25]. Moreover, in addition to the ER and plasma membrane, STIM1 is also colocalized with EB1 [65, 66], the cargo protein located at the plus ends of microtubules. Further experiments revealed that STIM1 was actively transported to the front ER assisting cell migration [25]. Therefore, STIM1 together with other Ca²⁺ channels is meticulously regulated in a spatial manner maintaining cell polarity and motility.

Table 1: Roles of store-operated Ca²⁺ (SOC) influx on cancer cell migration.

Gene(s)/Protein(s)
Cell type
Highlight
Target(s)
Reference

ORAI1
Esophageal squamous cell carcinoma (ESCC)
ORAI1 controls intracellular Ca²⁺ oscillations
N.A.
[105]

ORAI1 and STIM1
Clear cell renal cell carcinoma (ccRCC)
ORAI1 and STIM1 regulate cell proliferation and migration
N.A.
[106]

ORAI1 and STIM2
Melanoma cell lines
ORAI1 and STIM2 control melanoma growth and invasion in opposite manners
N.A.
[107]

ORAI1
Breast cancer cells
cAMP-PKA pathway decreases SK3 channel and SK3-ORAI1 complex activities, reducing Ca²⁺ entry and cancer cell migration
cAMP, PKA
[108]

STIM1
Breast cancer cell line MDA-MB-435s
Targeting SK3-ORAI1 in lipid rafts may inhibit bone metastasis
SK3
[109]

STIM1
Cervical cancer cell lines (SiHa, HT-3, CaSki, and HeLa)
HDAC6 may disrupt STIM1-mediated SOC influx and block malignant cell behavior
HDAC6
[110]

ORAI1 and STIM1
Glioblastoma multiforme (GBM)
STIM1 and ORAI1 affect the invasion of GBM cells
N.A.
[111]

ORAI1
Human T cell leukemia line, Jurkat cell
Monoclonal antibodies against ORAI1 reduce SOC influx, NFAT transcription, and cytokine release
N.A.
[112]

ORAI1
Human prostate cancer (PCa) cell
Bisphenol A pretreatment enhances SOC influx and ORAI1 protein in LNCaP cells; it also induces PCa cells migration
N.A.
[113]

STIM1
Cervical cancer cell
STIM1 regulates actomyosin reorganization and contractile forces to control cell migration
Actomyosin
[114]

STIM1
Hepatocellular carcinoma and hepatocyte cell lines
STIM1 level predicts prognosis in patients of liver cancer
N.A.
[115]

STIM1
Human epidermoid carcinoma A431 cells
STIM1 regulates SOC influx, cell proliferation, and tumorigenicity
N.A.
[116]

STIM1
Cervical cancer SiHa and CaSki cell lines
STIM1 regulates cervical cancer growth, migration, and angiogenesis
Focal adhesion, Pyk2
[7]

ORAI1 and STIM1
MDA-MB-231 human breast cancer cells
Blocking STIM1 or ORAI1 using RNA interference or small molecule inhibitors decreased tumor metastasis in animal models
Focal adhesion
[82]

Table 2: Roles of store-operated SOC influx on the motility of nonmalignant cells.

Gene(s)/Protein(s)
Cell type
Highlight
Target(s)
Reference

STIM1
Endothelial progenitor cells (EPCs)
STIM1 affects EPCs proliferation and migration after vascular injury by regulating Ca²⁺ levels
N.A.
[117]

ORAI1
HEK293
Selective activation of NFAT by ORAI1
NFAT
[118]

STIM1
Endothelial leader cells
Cells employ an integrated and polarized Ca²⁺ signalling system for directed cell migration
PLC pathway
[25]

ORAI1
Keratinocytes
ORAI1-mediated Ca²⁺ entry enhances the turnover of focal adhesion through PKCβ, calpain, and focal adhesion kinase
PKC pathway
[119]

ORAI1 and STIM1
Retinal pigment epithelial cells (ARPE-19 cell line)
STIM1, ORAI1, ERK 1/2, and Akt determine EGF-mediated cell growth
MAPK pathway
[120]

STIM1
HEK293
STIM regulates focal adhesion dynamics
Focal adhesion
[121]

ORAI1 and STIM1
Airway smooth muscle cell (ASMC)
STIM1 or ORAI1 controls PDGF-mediated ASMC proliferation and chemotactic migration
N.A.
[122]

ORAI1 and STIM1
ASMC
STIM1 and ORAI1 control PDGF-induced cell migration and Ca²⁺ influx
N.A.
[123]

STIM1
Intestinal epithelial cell (IEC)
Polyamines control TRPC1-mediated Ca²⁺ signaling and cell migration via differential STIM1 and STIM2 levels
TRPC1
[124]

ORAI1 and STIM1
Vascular smooth muscle cells (VSMC)
STIM1- and ORAI1-mediated SOC influx regulates angiotensin II-induced VSMC proliferation
N.A.
[125]

STIM1
EPCs
STIM1 regulates the proliferation and migration of EPCs
N.A.
[126]

ORAI1 and STIM1
VSMC
STIM1 and ORAI1 regulate PDGF-mediated Ca²⁺ entry and migration in VSMC
N.A.
[127]

ORAI1 and STIM1
VSMC
Knockdown of STIM1 and ORAI1, but not STIM2, Orai2, or Orai3, reduces VSMC proliferation and migration
N.A.
[128]

4. Ca²⁺ Effectors for Cell Migration (Figure 4)

As described above, intracellular Ca²⁺ is regulated locally and globally for effective cytoskeletal remodeling, cell migration, and cancer metastasis. Ca²⁺ pulses and spikes occur at the right place and right time, activating numerous downstream structural and signaling targets, which have been investigated separately over the past decades. The clarification of Ca²⁺ signaling in recent years has dramatically improved our understanding about how those components are regulated temporally and spatially in migrating cells. However, such advancement has revealed more questions than answers. More efforts are required to resolve those problems in the future.

4.1. Signaling-Related Targets

4.1.1. Protein Kinase C (PKC)

PKC is a typical downstream target of Ca²⁺ in receptor tyrosine kinase signaling pathways, during which the growth factor binds to the receptor and activates its tyrosine kinase through dimerization and autophosphorylation [70]. The resulting activation of PLC generates diacylglycerol (DAG) and IP₃, which subsequently induces Ca²⁺ release from the ER. DAG and Ca²⁺ then bind separately to the C1 and C2 domains of classical PKC (PKCα, β, and γ) [71]. Depending on the substrate, classical PKC regulates a wide variety of physiological processes, including cell migration [72]. The action could be direct via phosphorylation or indirect through transcriptional activation.

The classical PKC family has direct and significant impact on cell migration. PKCα is enriched in the front of migrating cells [14]. It directly phosphorylates Rho GTPases and multiple components of focal adhesion complexes, regulating the remodeling of cell-matrix adhesion (see [73] for a more comprehensive review). PKCβ phosphorylates the heavy chains of myosin II, inhibiting myosin contraction and facilitating the process of directional determination in migrating cells [74–77]. How these PKCs respond to spatiotemporal Ca²⁺ signaling and coordinate for effective moving activities requires further investigation.

Besides classical PKCs, atypical PKCs [70] also regulate the polarity of migrating cells. Unlike classical PKCs, those PKCs do not require DAG or Ca²⁺ for activation [70]. Together with Rho GTPases [78, 79], these PKCs might be actively involved in the dynamic processes of cell protrusion and adhesion [78, 80]. How these actions synchronize with the Ca²⁺ dynamics during cell migration also awaits more research in the future.

4.1.2. Rho GTPases

Rho GTPases, including Rac1, RhoA, and Cdc42, have been known as the key components for the regulation of actin dynamics [81]. It is therefore not surprising to see their active involvement in cell migration. Spatially, in a simplified model, these GTPases are enriched at specific structures of a migrating cell, Rac1 in lamellipodia, RhoA around focal adhesion complexes, and Cdc42 near filopodia [8]. Temporally, activities of these GTPases are pulsatile and also synchronized to the cyclic lamellipodial activities in the front of migrating cells [29]. Therefore, Rho GTPases, similar to Ca²⁺ [24], exert actions at the right place and right time for proper actin remodeling and efficient cell migration.

Although the present data reveals no evidence of direct binding between Ca²⁺ and Rho GTPases, it is reasonable to expect their mutual interactions considering their perfect coordination during cell migration [24, 29, 30]. Such speculation is supported by the observation that blocking Ca²⁺ influx at the leading edges of polarized macrophages resulted in the disassembly of actin filaments and lamellipodia activities [14]. The facts that constitutively active Rac1 fully rescued the effects of SOC influx inhibition in migrating breast cancer cells [82] also indicate the regulatory role of Ca²⁺ on Rho GTPases. Moreover, the transamidation of Rac1 was shown to be dependent on intracellular Ca²⁺ and calmodulin in rat cortical cells, suggesting the biochemical link between Rho GTPases and Ca²⁺ signaling [83]. Hopefully more studies will be conducted in the near future to clarify the mechanism of how Ca²⁺ interacts with Rho GTPases.

4.2. Cytoskeleton-Related Targets

4.2.1. Myosin II

As mentioned above, local Ca²⁺ pulses at the junction of lamellipodia and lamella activate MLCK [24], which subsequently phosphorylates myosin light chain and triggers myosin contraction. It is worth noticing that the affinity between MLCK and myosin-calmodulin is extremely high, with the dissociation constant () of about 1 nM [33]. Therefore, a slight increase of local Ca²⁺ concentration is sufficient to induce significant activation of MLCK and subsequent contraction of myosin II. Moreover, the high sensitivity of MLCK to Ca²⁺ implies that the front cytoplasm has to be free of Ca²⁺ at the basal status, so MLCK can be inactive at baseline but respond to small rises of Ca²⁺ promptly. Such design justifies the physiological importance of the front-low, back-high Ca²⁺ gradient in migrating cells.

In cell migration, the immediate effect of myosin contraction is the retraction of actin bundles, which not only facilitates the disassembly of F-actin at lamella but also allows the protruding front to attach to the extracellular matrix [28, 31]. In addition, myosin contraction also stabilizes nascent focal adhesion complexes in the front of migrating cells [32, 84]. This is probably because these contractions apply traction force on the complexes through actin bundles binding to them. Such force subsequently induces remodeling and stabilization of the components in focal adhesion. Therefore, through MLCK and myosin II, local Ca²⁺ pulses are tightly linked to the oscillatory dynamics of cell protrusion, retraction, and adhesion.

4.2.2. Actin

Besides myosin, Ca²⁺ also affects the dynamics of actin, the major component of cytoskeleton [85, 86]. Although Ca²⁺ does not directly bind to actin, it affects the activities of multiple actin regulators. First of all, Ca²⁺ activates protein kinase C and calmodulin-dependent kinases, both of which interact with actin affecting its dynamics [87–89]. Secondly, as also described above, Ca²⁺ signaling regulates the Rho GTPases [14], which are mandatory for the formation of actin bundles for lamellipodia, focal adhesion complexes, and filopodia [8], the major components for cell migration. In addition, the F-actin severing protein cofilin [90, 91] also depends on the cytosolic Ca²⁺ for its proper activity. Moreover, myosin, as one the major actin regulators, is totally dependent on Ca²⁺ for its proper activity [24]. Therefore, though not a direct regulator, Ca²⁺ modulates actin dynamics through multiple signaling pathways and structural molecules.

4.3. Adhesion-Related Targets

4.3.1. Calpain

In addition to kinase activities and physical force, Ca²⁺ also affects cell migration through protein cleavage and degradation. Calpain, as a Ca²⁺-dependent intracellular protease [92, 93], is involved in the turnover of stable focal adhesion complexes, probably at the rear end of migrating cells. Calpain has been revealed to cleave several components of the focal adhesion complex, including talin [94], paxillin [95], and focal adhesion kinases [96], compatible with previous reports showing that Ca²⁺ influx at the back of migrating cells facilitated retraction and detachment at their rear ends [97]. Beside focal adhesion, calpain also degrades PMCA [62]. Since there is an inverse correlation between the front-back gradients of Ca²⁺ and PMCA in migrating cells [25], decreased amount of PMCA in the cell back may result from the higher Ca²⁺ level and higher calpain activity in the back than in the front. However, such speculation requires more experimental data to be validated.

4.3.2. Pyk2 and Other Molecules

In addition to calpain, several adhesion-related proteins are also regulated by Ca²⁺, including Pyk2, plectin, and matrix metallopeptidases.

As a cytoplasmic protein tyrosine kinase, Pyk2 is activated by intracellular Ca²⁺ and protein kinase C [98]. It regulates the activities of focal adhesion kinase and GRB2, affecting focal adhesion complexes [99] and the MAP kinase signaling pathway [98]. In human cervical cancer cells, aberrant SOC influx changes focal adhesion dynamics through Pyk2 dysregulation [7].

Ca²⁺ also regulates the conveyance of integrin-based signaling into the cytoskeleton, with its interaction with plectin, the bridge between integrin complexes and actin filaments. Recent biochemical and biophysical evidence indicated that the binding of plectin 1a with Ca²⁺ effectively decreased its interactions with integrin β and with F-actin, decoupling cell-matrix adhesion with cytoskeletal structures [100, 101]. We may speculate that, with proper temporal and spatial Ca²⁺ regulation, cells could determine how many environmental signals would be conducted into the cells for cytoskeleton modification. More studies are required to clarify the above hypothesis.

Furthermore, matrix metallopeptidases (MMP), as facilitating factors for cancer metastasis, are also regulated by intracellular Ca²⁺. In prostate cancer, increased expression of TRPV2 elevated cytosolic Ca²⁺ levels, which enhanced MMP9 expression and cancer cell aggressiveness [102]. Further investigation in melanoma cells revealed that increased intracellular Ca²⁺ induced the binding of Ca²⁺-modulating cyclophilin ligand to basigin, stimulating the production of MMP [103]. Therefore, Ca²⁺ not only modulates the outside-in (integrin to actin) signaling but also regulates the inside-out (Ca²⁺ to MMP) signaling for cell migration and cancer metastasis.

5. Future: Interactions between Ca²⁺ and Other Signaling Pathways

Regarding the complicated temporal and spatial regulation of Ca²⁺ signaling in migrating cells, we would expect extensive interactions between Ca²⁺ and other signaling modules during cell migration. Indeed, though still preliminary, recent work has revealed potential cross talk between Ca²⁺ and other pathways controlling cell motility. These findings will shed new light on our pilgrimage toward a panoramic view of cell migration machinery.

5.1. Interactions between SOC Influx and Cell-Matrix Adhesion

In the present model, SOC influx maintains Ca²⁺ storage in the ER, which releases local Ca²⁺ pulses to enhance the formation of nascent focal adhesion complexes [25]. Therefore, the inhibition of SOC influx should weaken cell-matrix adhesion. Interestingly, STIM1, the Ca²⁺ sensor for the activation of the SOC influx, had been reported as an oncogene [82] or a tumor suppressor gene [104] by different groups. Furthermore, although most recent research suggested a positive role of STIM1 on cancer cell motility (Table 1), other reports revealed the opposite results in primary cells (Table 2). Therefore, effects of SOC influx on cell migration might vary under different circumstances.

One possible explanation of the confusing results uses the interaction between Ca²⁺ and basal cell-matrix adhesion. Primary cells are usually well attached to the matrix, so further enhancing their adhesion capability might trap them in the matrix and deter them from moving forward. In contrast, metastatic cancer cells often have weak cell-matrix adhesion, so strengthening their attachment to the matrix facilitates the completion of cell migration cycles. Indeed, recent evidence suggested that, in an in vitro cell migration assay [25], SOC influx might increase or decrease the motility of the same cell type depending on concentrations of fibronectin for the cells to attach. Though further explorations are required to validate the present data, the combination of SOC influx inhibition and cell-matrix adhesion blockage might be a novel approach to prevent cancer metastasis.

5.2. Coordination between the Oscillations of Ca²⁺ and Rho GTPases

Previous reports have revealed the oscillatory activities of Rho GTPases in the front of migrating cells, including Rac1, RhoA, and Cdc42 [29, 30]. These molecules regulate actin dynamics and coordinate with the pulsatile lamellipodial activities. Since the oscillation of local Ca²⁺ pulses synchronize with the retraction phases of lamellipodial cycles [24], there probably exists cross talk between Ca²⁺ signaling and Rho GTPases. Clarifying how these molecules are regulated to coordinate with each other will dramatically improve our understanding of lamellipodia and help developing better strategies to control physiological and pathological cell migration.

5.3. Link between Ca²⁺, RTK, and Lipid Signaling

The meticulous spatial control of Ca²⁺ signaling in migrating cells, together with the enrichment of RTK, phosphatidylinositol (3,4,5)-triphosphate (PIP₃), and DAG in the cell front [25], reveals the complicated nature of the migration polarity machinery. How these signaling pathways act together to determine the direction for cells to move remains elusive and requires more research. In addition, understanding how nonpulsatile RTK and lipid signaling exert effects on oscillatory Ca²⁺ pulses will improve our knowledge about the spatial and temporal regulation of signal transduction inside the cells. Such information will further enhance our capability to develop novel strategies targeting pathological processes and manipulating diseases.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

R. Masuyama, “Role of local vitamin D signaling and cellular calcium transport system in bone homeostasis,” Journal of Bone and Mineral Metabolism, vol. 32, no. 1, pp. 1–9, 2014.

I. Calin-Jageman and A. Lee, “Cav1 L-type Ca²⁺ channel signaling complexes in neurons,” Journal of Neurochemistry, vol. 105, no. 3, pp. 573–583, 2008.

X. Zhao, D. Yamazaki, S. Kakizawa, Z. Pan, H. Takeshima, and J. Ma, “Molecular architecture of Ca²⁺ signaling control in muscle and heart cells,” Channels, vol. 5, no. 5, pp. 391–396, 2011.

D. E. Clapham, “Calcium Signaling,” Cell, vol. 131, no. 6, pp. 1047–1058, 2007.

F. M. LaFerla, “Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 3, no. 11, pp. 862–872, 2002.

P. J. Shaw and S. Feske, “Physiological and pathophysiological functions of SOCE in the immune system,” Frontiers in Bioscience (Elite Edition), vol. 4, no. 6, pp. 2253–2268, 2012.

Y.-F. Chen, W.-T. Chiu, Y.-T. Chen et al., “Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 37, pp. 15225–15230, 2011.

A. J. Ridley, M. A. Schwartz, K. Burridge et al., “Cell migration: integrating signals from front to back,” Science, vol. 302, no. 5651, pp. 1704–1709, 2003.

L. Lamalice, F. Le Boeuf, and J. Huot, “Endothelial cell migration during angiogenesis,” Circulation Research, vol. 100, no. 6, pp. 782–794, 2007.

B. A. Imhof and D. Dunon, “Basic mechanism of leukocyte migration,” Hormone and Metabolic Research, vol. 29, no. 12, pp. 614–621, 1997.

S. Hanna and A. Etzioni, “Leukocyte adhesion deficiencies,” Annals of the New York Academy of Sciences, vol. 1250, no. 1, pp. 50–55, 2012.

S. Barrientos, O. Stojadinovic, M. S. Golinko, H. Brem, and M. Tomic-Canic, “Growth factors and cytokines in wound healing,” Wound Repair and Regeneration, vol. 16, no. 5, pp. 585–601, 2008.

M. Vicente-Manzanares and A. R. Horwitz, “Cell migration: an overview,” Methods in Molecular Biology, vol. 769, pp. 1–24, 2011.

J. H. Evans and J. J. Falke, “Ca²⁺ influx is an essential component of the positive-feedback loop that maintains leading-edge structure and activity in macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 41, pp. 16176–16181, 2007.

G. Grynkiewicz, M. Poenie, and R. Y. Tsien, “A new generation of Ca2+ indicators with greatly improved fluorescence properties,” The Journal of Biological Chemistry, vol. 260, no. 6, pp. 3440–3450, 1985.

R. Y. Tsien, T. J. Rink, and M. Poenie, “Measurement of cytosolic free Ca²⁺ in individual small cells using fluorescence microscopy with dual excitation wavelengths,” Cell Calcium, vol. 6, no. 1-2, pp. 145–157, 1985.

R. A. Brundage, K. E. Fogarty, R. A. Tuft, and F. S. Fay, “Calcium gradients underlying polarization and chemotaxis of eosinophils,” Science, vol. 254, no. 5032, pp. 703–706, 1991.

C. Wei, X. Wang, M. Chen, K. Ouyang, L.-S. Song, and H. Cheng, “Calcium flickers steer cell migration,” Nature, vol. 457, no. 7231, pp. 901–905, 2009.

J. T. H. Mandeville, R. N. Ghosh, and F. R. Maxfield, “Intracellular calcium levels correlate with speed and persistent forward motion in migrating neutrophils,” Biophysical Journal, vol. 68, no. 4, pp. 1207–1217, 1995.

J. Elf, G.-W. Li, and X. S. Xie, “Probing transcription factor dynamics at the single-molecule level in a living cell,” Science, vol. 316, no. 5828, pp. 1191–1194, 2007.

K. L. Rogers, J.-R. Martin, O. Renaud et al., “Electron-multiplying charge-coupled detector-based bioluminescence recording of single-cell Ca²⁺,” Journal of Biomedical Optics, vol. 13, no. 3, Article ID 031211, 2008.

M. Mank and O. Griesbeck, “Genetically encoded calcium indicators,” Chemical Reviews, vol. 108, no. 5, pp. 1550–1564, 2008.

T.-W. Chen, T. J. Wardill, Y. Sun et al., “Ultrasensitive fluorescent proteins for imaging neuronal activity,” Nature, vol. 499, no. 7458, pp. 295–300, 2013.

F.-C. Tsai and T. Meyer, “Ca²⁺ pulses control local cycles of lamellipodia retraction and adhesion along the front of migrating cells,” Current Biology, vol. 22, no. 9, pp. 837–842, 2012.

F.-C. Tsai, A. Seki, H. W. Yang et al., “A polarized Ca²⁺, diacylglycerol and STIM1 signalling system regulates directed cell migration,” Nature Cell Biology, vol. 16, no. 2, pp. 133–144, 2014.

J. V. Small, T. Stradal, E. Vignal, and K. Rottner, “The lamellipodium: where motility begins,” Trends in Cell Biology, vol. 12, no. 3, pp. 112–120, 2002.

D. J. Webb, J. T. Parsons, and A. F. Horwitz, “Adhesion assembly, disassembly and turnover in migrating cells—over and over and over again,” Nature Cell Biology, vol. 4, no. 4, pp. E97–E100, 2002.

D. T. Burnette, S. Manley, P. Sengupta et al., “A role for actin arcs in the leading-edge advance of migrating cells,” Nature Cell Biology, vol. 13, no. 4, pp. 371–382, 2011.

M. MacHacek, L. Hodgson, C. Welch et al., “Coordination of Rho GTPase activities during cell protrusion,” Nature, vol. 461, no. 7260, pp. 99–103, 2009.

E. Tkachenko, M. Sabouri-Ghomi, O. Pertz et al., “Protein kinase A governs a RhoA-RhoGDI protrusion-retraction pacemaker in migrating cells,” Nature Cell Biology, vol. 13, no. 6, pp. 660–667, 2011.

G. Giannone, B. J. Dubin-Thaler, H.-G. Döbereiner, N. Kieffer, A. R. Bresnick, and M. P. Sheetz, “Periodic lamellipodial contractions correlate with rearward actin waves,” Cell, vol. 116, no. 3, pp. 431–443, 2004.

G. Giannone, B. J. Dubin-Thaler, O. Rossier et al., “Lamellipodial actin mechanically links myosin activity with adhesion-site formation,” Cell, vol. 128, no. 3, pp. 561–575, 2007.

R. Kasturi, C. Vasulka, and J. D. Johnson, “Ca²⁺, caldesmon, and myosin light chain kinase exchange with calmodulin,” The Journal of Biological Chemistry, vol. 268, no. 11, pp. 7958–7964, 1993.

M. J. Berridge, “Inositol trisphosphate and calcium signalling,” Nature, vol. 361, no. 6410, pp. 315–325, 1993.

C. W. Taylor, Taufiq-Ur-Rahman, and E. Pantazaka, “Targeting and clustering of IP3 receptors: key determinants of spatially organized Ca²⁺ signals,” Chaos, vol. 19, no. 3, Article ID 037102, 2009.

K. Qin, C. Dong, G. Wu, and N. A. Lambert, “Inactive-state preassembly of Gq-coupled receptors and Gq heterotrimers,” Nature Chemical Biology, vol. 7, no. 10, pp. 740–747, 2011.

B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter, Molecular Biology of the Cell, Garland Science, 4th edition, 2002.

R. Jacob, J. E. Merritt, T. J. Hallam, and T. J. Rink, “Repetitive spikes in cytoplasmic calcium evoked by histamine in human endothelial cells,” Nature, vol. 335, no. 6185, pp. 40–45, 1988.

L. Giri, A. K. Patel, W. K. A. Karunarathne, V. Kalyanaraman, K. V. Venkatesh, and N. Gautam, “A G-protein subunit translocation embedded network motif underlies GPCR regulation of calcium oscillations,” Biophysical Journal, vol. 107, no. 1, pp. 242–254, 2014.

E. G. Levin, “Cancer therapy through control of cell migration,” Current Cancer Drug Targets, vol. 5, no. 7, pp. 505–518, 2005.

J. Grahovac and A. Wells, “Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion,” Laboratory Investigation, vol. 94, no. 1, pp. 31–40, 2014.

A. Angelucci and M. Bologna, “Targeting vascular cell migration as a strategy for blocking angiogenesis: the central role of focal adhesion protein tyrosine kinase family,” Current Pharmaceutical Design, vol. 13, no. 21, pp. 2129–2145, 2007.

O. H. Petersen, “Stimulus-secretion coupling: cytoplasmic calcium signals and the control of ion channels in exocrine acinar cells,” Journal of Physiology, vol. 448, pp. 1–51, 1992.

P. Thorn, A. M. Lawrie, P. M. Smith, D. V. Gallacher, and O. H. Petersen, “Local and global cytosolic Ca²⁺ oscillations in exocrine cells evoked by agonists and inositol trisphosphate,” Cell, vol. 74, no. 4, pp. 661–668, 1993.

E. A. Finch, T. J. Turner, and S. M. Goldin, “Calcium as a coagonist of inositol 1,4,5-trisphosphate-induced calcium release,” Science, vol. 252, no. 5004, pp. 443–446, 1991.

J. Keizer and L. Levine, “Ryanodine receptor adaptation and Ca²⁺(−)induced Ca²⁺ release- dependent Ca²⁺ oscillations,” Biophysical Journal, vol. 71, no. 6, pp. 3477–3487, 1996.

A. Di and A. B. Malik, “TRP channels and the control of vascular function,” Current Opinion in Pharmacology, vol. 10, no. 2, pp. 127–132, 2010.

N. Nielsen, O. Lindemann, and A. Schwab, “TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration,” British Journal of Pharmacology, vol. 171, no. 24, pp. 5524–5540, 2014.

H. Gao, X. Chen, X. Du, B. Guan, Y. Liu, and H. Zhang, “EGF enhances the migration of cancer cells by up-regulation of TRPM7,” Cell Calcium, vol. 50, no. 6, pp. 559–568, 2011.

J. Middelbeek, A. J. Kuipers, L. Henneman et al., “TRPM7 is required for breast tumor cell metastasis,” Cancer Research, vol. 72, no. 16, pp. 4250–4261, 2012.

J.-P. Chen, Y. Luan, C.-X. You, X.-H. Chen, R.-C. Luo, and R. Li, “TRPM7 regulates the migration of human nasopharyngeal carcinoma cell by mediating Ca²⁺ influx,” Cell Calcium, vol. 47, no. 5, pp. 425–432, 2010.

B. Roy, T. Das, D. Mishra, T. K. Maiti, and S. Chakraborty, “Oscillatory shear stress induced calcium flickers in osteoblast cells,” Integrative Biology, vol. 6, no. 3, pp. 289–299, 2014.

L.-T. Su, M. A. Agapito, M. Li et al., “TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain,” The Journal of Biological Chemistry, vol. 281, no. 16, pp. 11260–11270, 2006.

D. H. MacLennan and E. G. Kranias, “Phospholamban: a crucial regulator of cardiac contractility,” Nature Reviews Molecular Cell Biology, vol. 4, no. 7, pp. 566–577, 2003.

J. Liou, M. L. Kim, D. H. Won et al., “STIM is a Ca²⁺ sensor essential for Ca²⁺-store- depletion-triggered Ca²⁺ influx,” Current Biology, vol. 15, no. 13, pp. 1235–1241, 2005.

W.-F. Gou, Z.-F. Niu, S. Zhao, Y. Takano, and H.-C. Zheng, “Aberrant SERCA3 expression during the colorectal adenoma-adenocarcinoma sequence,” Oncology Reports, vol. 31, no. 1, pp. 232–240, 2014.

F.-Y. Chung, S.-R. Lin, C.-Y. Lu et al., “Sarco/endoplasmic reticulum calcium-ATPase 2 expression as a tumor marker in colorectal cancer,” The American Journal of Surgical Pathology, vol. 30, no. 8, pp. 969–974, 2006.

E. Abell, R. Ahrends, S. Bandara, B. O. Park, and M. N. Teruel, “Parallel adaptive feedback enhances reliability of the Ca²⁺ signaling system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 35, pp. 14485–14490, 2011.

E. E. Strehler and M. Treiman, “Calcium pumps of plasma membrane and cell interior,” Current Molecular Medicine, vol. 4, no. 3, pp. 323–335, 2004.

P. James, M. Maeda, R. Fischer et al., “Identification and primary structure of a calmodulin binding domain of the Ca²⁺ pump of human erythrocytes,” The Journal of Biological Chemistry, vol. 263, no. 6, pp. 2905–2910, 1988.

P. H. James, M. Pruschy, T. E. Vorherr, J. T. Penniston, and E. Carafoli, “Primary structure of the cAMP-dependent phosphorylation site of the plasma membrane calcium pump,” Biochemistry, vol. 28, no. 10, pp. 4253–4258, 1989.

P. James, T. Vorherr, J. Krebs et al., “Modulation of erythrocyte Ca²⁺-ATPase by selective calpain cleavage of the calmodulin-binding domain,” The Journal of Biological Chemistry, vol. 264, no. 14, pp. 8289–8296, 1989.

J. W. Putney Jr., “Capacitative calcium entry: sensing the calcium stores,” Journal of Cell Biology, vol. 169, no. 3, pp. 381–382, 2005.

O. Brandman, J. Liou, W. S. Park, and T. Meyer, “STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca²⁺ levels,” Cell, vol. 131, no. 7, pp. 1327–1339, 2007.

I. Grigoriev, S. M. Gouveia, B. van der Vaart et al., “STIM1 is a MT-plus-end-tracking protein involved in remodeling of the ER,” Current Biology, vol. 18, no. 3, pp. 177–182, 2008.

S. Honnappa, S. M. Gouveia, A. Weisbrich et al., “An EB1-binding motif acts as a microtubule tip localization signal,” Cell, vol. 138, no. 2, pp. 366–376, 2009.

J. Liou, M. Fivaz, T. Inoue, and T. Meyer, “Live-cell imaging reveals sequential oligomerization and local plasma membrane targeting of stromal interaction molecule 1 after Ca²⁺ store depletion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 22, pp. 9301–9306, 2007.

S. Feske, Y. Gwack, M. Prakriya et al., “A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function,” Nature, vol. 441, no. 7090, pp. 179–185, 2006.

M. Prakriya, S. Feske, Y. Gwack, S. Srikanth, A. Rao, and P. G. Hogan, “Orai1 is an essential pore subunit of the CRAC channel,” Nature, vol. 443, no. 7108, pp. 230–233, 2006.

C. Rosse, M. Linch, S. Kermorgant, A. J. M. Cameron, K. Boeckeler, and P. J. Parker, “PKC and the control of localized signal dynamics,” Nature Reviews Molecular Cell Biology, vol. 11, no. 2, pp. 103–112, 2010.

H. Mellor and P. J. Parker, “The extended protein kinase C superfamily,” Biochemical Journal, vol. 332, part 2, pp. 281–292, 1998.

H. P. Rang, M. M. Dale, J. M. Ritter, R. J. Flower, and G. Henderson, Rang & Dale's Pharmacology, Churchill Livingstone, Edinburgh, UK, 7th edition, 2011.

B. S. Fogh, H. A. B. Multhaupt, and J. R. Couchman, “Protein kinase C, focal adhesions and the regulation of cell migration,” Journal of Histochemistry and Cytochemistry, vol. 62, no. 3, pp. 172–184, 2014.

N. Murakami, S. S. Singh, V. P. Chauhan, and M. Elzinga, “Phospholipid binding, phosphorylation by protein kinase C, and filament assembly of the COOH terminal heavy chain fragments of nonmuscle myosin II isoforms MIIA and MIIB,” Biochemistry, vol. 34, no. 49, pp. 16046–16055, 1995.

N. Murakami, V. P. S. Chauhan, and M. Elzinga, “Two nonmuscle myosin II heavy chain isoforms expressed in rabbit brains: filament forming properties, the effects of phosphorylation by protein kinase C and casein kinase II, and location of the phosphorylation sites,” Biochemistry, vol. 37, no. 7, pp. 1989–2003, 1998.

N. G. Dulyaninova, V. N. Malashkevich, S. C. Almo, and A. R. Bresnick, “Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylation,” Biochemistry, vol. 44, no. 18, pp. 6867–6876, 2005.

N. G. Dulyaninova, R. P. House, V. Betapudi, and A. R. Bresnick, “Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells,” Molecular Biology of the Cell, vol. 18, no. 8, pp. 3144–3155, 2007.

S. Etienne-Manneville and A. Hall, “Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCζ,” Cell, vol. 106, no. 4, pp. 489–498, 2001.

S. Etienne-Manneville and A. Hall, “Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity,” Nature, vol. 421, no. 6924, pp. 753–756, 2003.

C. Rosse, E. Formstecher, K. Boeckeler et al., “An aPKC-Exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation,” PLoS Biology, vol. 7, no. 11, Article ID e1000235, 2009.

X. R. Bustelo, V. Sauzeau, and I. M. Berenjeno, “GTP-binding proteins of the Rho/Rac family: Regulation, effectors and functions in vivo,” BioEssays, vol. 29, no. 4, pp. 356–370, 2007.

S. Yang, J. J. Zhang, and X.-Y. Huang, “Orai1 and STIM1 are critical for breast tumor cell migration and metastasis,” Cancer Cell, vol. 15, no. 2, pp. 124–134, 2009.

Y. Dai, N. L. Dudek, Q. Li, and N. A. Muma, “Phospholipase C, Ca²⁺, and calmodulin signaling are required for 5-HT2A receptor-mediated transamidation of Rac1 by transglutaminase,” Psychopharmacology, vol. 213, no. 2-3, pp. 403–412, 2011.

P. Kanchanawong, G. Shtengel, A. M. Pasapera et al., “Nanoscale architecture of integrin-based cell adhesions,” Nature, vol. 468, no. 7323, pp. 580–584, 2010.

E. Mostafavi, A. A. Nargesi, Z. Ghazizadeh et al., “The degree of resistance of erythrocyte membrane cytoskeletal proteins to supra-physiologic concentrations of calcium: an in vitro study,” The Journal of Membrane Biology, vol. 247, no. 8, pp. 695–701, 2014.

F. Wang, D.-Z. Liu, H. Xu et al., “Thapsigargin induces apoptosis by impairing cytoskeleton dynamics in human lung adenocarcinoma cells,” The Scientific World Journal, vol. 2014, Article ID 619050, 7 pages, 2014.

Y. Ohta, E. Nishida, and H. Sakai, “Type II Ca²⁺/calmodulin-dependent protein kinase binds to actin filaments in a calmodulin-sensitive manner,” FEBS Letters, vol. 208, no. 2, pp. 423–426, 1986.

C. Larsson, “Protein kinase C and the regulation of the actin cytoskeleton,” Cellular Signalling, vol. 18, no. 3, pp. 276–284, 2006.

L. Hoffman, M. M. Farley, and M. N. Waxham, “Calcium-calmodulin-dependent protein kinase II isoforms differentially impact the dynamics and structure of the actin cytoskeleton,” Biochemistry, vol. 52, no. 7, pp. 1198–1207, 2013.

C.-B. Guan, H.-T. Xu, M. Jin, X.-B. Yuan, and M.-M. Poo, “Long-range Ca²⁺ signaling from growth cone to soma mediates reversal of neuronal migration induced by slit-2,” Cell, vol. 129, no. 2, pp. 385–395, 2007.

Z.-H. Huang, Y. Wang, Z.-D. Su et al., “Slit-2 repels the migration of olfactory ensheathing cells by triggering Ca²⁺-dependent cofilin activation and RhoA inhibition,” Journal of Cell Science, vol. 124, no. 2, pp. 186–197, 2011.

M. Nagano, D. Hoshino, N. Koshikawa, T. Akizawa, and M. Seiki, “Turnover of focal adhesions and cancer cell migration,” International Journal of Cell Biology, vol. 2012, Article ID 310616, 10 pages, 2012.

A. Glading, D. A. Lauffenburger, and A. Wells, “Cutting to the chase: calpain proteases in cell motility,” Trends in Cell Biology, vol. 12, no. 1, pp. 46–54, 2002.

S. J. Franco, M. A. Rodgers, B. J. Perrin et al., “Calpain-mediated proteolysis of talin regulates adhesion dynamics,” Nature Cell Biology, vol. 6, no. 10, pp. 977–983, 2004.

C. L. Cortesio, L. R. Boateng, T. M. Piazza, D. A. Bennin, and A. Huttenlocher, “Calpain-mediated proteolysis of paxillin negatively regulates focal adhesion dynamics and cell migration,” The Journal of Biological Chemistry, vol. 286, no. 12, pp. 9998–10006, 2011.

K. T. Chan, D. A. Bennin, and A. Huttenlocher, “Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK),” The Journal of Biological Chemistry, vol. 285, no. 15, pp. 11418–11426, 2010.

M. D. Sjaastad and W. J. Nelson, “Integrin-mediated calcium signaling and regulation of cell adhesion by intracellular calcium,” BioEssays, vol. 19, no. 1, pp. 47–55, 1997.

S. Lev, H. Moreno, R. Martinez et al., “Protein tyrosine kinase PYK2 involved in Ca²⁺-induced regulation of ion channel and MAP kinase functions,” Nature, vol. 376, no. 6543, pp. 737–745, 1995.

S. Avraham, R. London, Y. Fu et al., “Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain,” The Journal of Biological Chemistry, vol. 270, no. 46, pp. 27742–27751, 1995.

J. Kostan, M. Gregor, G. Walko, and G. Wiche, “Plectin isoform-dependent regulation of keratin-integrin α6β4 anchorage via Ca²⁺/calmodulin,” The Journal of Biological Chemistry, vol. 284, no. 27, pp. 18525–18536, 2009.

J.-G. Song, J. Kostan, F. Drepper et al., “Structural insights into Ca²⁺-calmodulin regulation of plectin 1a-integrin β4 interaction in hemidesmosomes,” Structure, vol. 23, no. 3, pp. 558–570, 2015.

M. Monet, V. Lehen'kyi, F. Gackiere et al., “Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance,” Cancer Research, vol. 70, no. 3, pp. 1225–1235, 2010.

T. Long, J. Su, W. Tang et al., “A novel interaction between calcium-modulating cyclophilin ligand and Basigin regulates calcium signaling and matrix metalloproteinase activities in human melanoma cells,” Cancer Letters, vol. 339, no. 1, pp. 93–101, 2013.

E. Suyama, R. Wadhwa, K. Kaur et al., “Identification of metastasis-related genes in a mouse model using a library of randomized ribozymes,” The Journal of Biological Chemistry, vol. 279, no. 37, pp. 38083–38086, 2004.

H. Zhu, H. Zhang, F. Jin et al., “Elevated Orai1 expression mediates tumor-promoting intracellular Ca²⁺ oscillations in human esophageal squamous cell carcinoma,” Oncotarget, vol. 5, pp. 3455–3471, 2014.

J.-H. Kim, S. Lkhagvadorj, M.-R. Lee et al., “Orai1 and STIM1 are critical for cell migration and proliferation of clear cell renal cell carcinoma,” Biochemical and Biophysical Research Communications, vol. 448, no. 1, pp. 76–82, 2014.

H. Stanisz, S. Saul, C. S. L. Müller et al., “Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry,” Pigment Cell and Melanoma Research, vol. 27, no. 3, pp. 442–453, 2014.

L. Clarysse, M. Guéguinou, M. Potier-Cartereau et al., “cAMP-PKA inhibition of SK3 channel reduced both Ca²⁺ entry and cancer cell migration by regulation of SK3-Orai1 complex,” Pflügers Archiv, vol. 466, no. 10, pp. 1921–1932, 2014.

A. Chantôme, M. Potier-Cartereau, L. Clarysse et al., “Pivotal role of the lipid raft SK3-orai1 complex in human cancer cell migration and bone metastases,” Cancer Research, vol. 73, no. 15, pp. 4852–4861, 2013.

Y.-T. Chen, Y.-F. Chen, W.-T. Chiu et al., “Microtubule-associated histone deacetylase 6 supports the calcium store sensor STIM1 in mediating malignant cell behaviors,” Cancer Research, vol. 73, no. 14, pp. 4500–4509, 2013.

R. K. Motiani, M. C. Hyzinski-García, X. Zhang et al., “STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion,” Pflugers Archiv European Journal of Physiology, vol. 465, no. 9, pp. 1249–1260, 2013.

M. L. Greenberg, Y. Yu, S. Leverrier, S. L. Zhang, I. Parker, and M. D. Cahalan, “Orai1 function is essential for T cell homing to lymph nodes,” Journal of Immunology, vol. 190, no. 7, pp. 3197–3206, 2013.

S. Derouiche, M. Warnier, P. Mariot et al., “Bisphenol A stimulates human prostate cancer cell migration via remodelling of calcium signalling,” SpringerPlus, vol. 2, article 54, 2013.

Y.-T. Chen, Y.-F. Chen, W.-T. Chiu, Y.-K. Wang, H.-C. Chang, and M.-R. Shen, “The ER Ca²⁺ sensor STIM1 regulates actomyosin contractility of migratory cells,” Journal of Cell Science, vol. 126, no. 5, pp. 1260–1267, 2013.

N. Yang, Y. Tang, F. Wang et al., “Blockade of store-operated Ca²⁺ entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover,” Cancer Letters, vol. 330, no. 2, pp. 163–169, 2013.

J. Yoshida, K. Iwabuchi, T. Matsui, T. Ishibashi, T. Masuoka, and M. Nishio, “Knockdown of stromal interaction molecule 1 (STIM1) suppresses store-operated calcium entry, cell proliferation and tumorigenicity in human epidermoid carcinoma A431 cells,” Biochemical Pharmacology, vol. 84, no. 12, pp. 1592–1603, 2012.

X.-P. Cong, W.-H. Wang, X. Zhu, C. Jin, L. Liu, and X.-M. Li, “Silence of STIM1 attenuates the proliferation and migration of EPCs after vascular injury and its mechanism,” Asian Pacific Journal of Tropical Medicine, vol. 7, no. 5, pp. 373–377, 2014.

P. Kar, K. Samanta, H. Kramer, O. Morris, D. Bakowski, and A. B. Parekh, “Dynamic assembly of a membrane signaling complex enables selective activation of NFAT by Orai1,” Current Biology, vol. 24, no. 12, pp. 1361–1368, 2014.

M. Vandenberghe, M. Raphaël, V. Lehen'kyi et al., “ORAI1 calcium channel orchestrates skin homeostasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 50, pp. E4839–E4848, 2013.

I.-H. Yang, Y.-T. Tsai, S.-J. Chiu et al., “Involvement of STIM1 and Orai1 in EGF-mediated cell growth in retinal pigment epithelial cells,” Journal of Biomedical Science, vol. 20, article 41, 2013.

C. Schäfer, G. Rymarczyk, L. Ding, M. T. Kirber, and V. M. Bolotina, “Role of molecular determinants of store-operated Ca²⁺ entry (Orai1, phospholipase A2 group 6, and STIM1) in focal adhesion formation and cell migration,” The Journal of Biological Chemistry, vol. 287, no. 48, pp. 40745–40757, 2012.

A. M. Spinelli, J. C. González-Cobos, X. Zhang et al., “Airway smooth muscle STIM1 and Orai1 are upregulated in asthmatic mice and mediate PDGF-activated SOCE, CRAC currents, proliferation, and migration,” Pflügers Archiv, vol. 464, no. 5, pp. 481–492, 2012.

N. Suganuma, S. Ito, H. Aso et al., “STIM1 regulates platelet-derived growth factor-induced migration and Ca²⁺ influx in human airway smooth muscle cells,” PLoS ONE, vol. 7, no. 9, Article ID e45056, 2012.

J. N. Rao, N. Rathor, R. Zhuang et al., “Polyamines regulate intestinal epithelial restitution through TRPC1-mediated Ca²⁺ signaling by differentially modulating STIM1 and STIM2,” The American Journal of Physiology—Cell Physiology, vol. 303, no. 3, pp. C308–C317, 2012.

R.-W. Guo, L.-X. Yang, M.-Q. Li, X.-H. Pan, B. Liu, and Y.-L. Deng, “Stim1-and Orai1-mediated store-operated calcium entry is critical for angiotensin II-induced vascular smooth muscle cell proliferation,” Cardiovascular Research, vol. 93, no. 2, pp. 360–370, 2012.

C.-Y. Kuang, Y. Yu, R.-W. Guo et al., “Silencing stromal interaction molecule 1 by RNA interference inhibits the proliferation and migration of endothelial progenitor cells,” Biochemical and Biophysical Research Communications, vol. 398, no. 2, pp. 315–320, 2010.

J. M. Bisaillon, R. K. Motiani, J. C. Gonzalez-Cobos et al., “Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration,” The American Journal of Physiology—Cell Physiology, vol. 298, no. 5, pp. C993–C1005, 2010.

M. Potier, J. C. Gonzalez, R. K. Motiani et al., “Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration,” The FASEB Journal, vol. 23, no. 8, pp. 2425–2437, 2009.